In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
James A KarlowskyMelanie R BaxterAndrew J WalktyPhilippe R S Lagacé-WiensDenice C BayHeather J AdamGeorge G ZhanelPublished in: The Journal of antimicrobial chemotherapy (2022)
Fosfomycin demonstrated in vitro activity against frequently encountered Gram-positive and Gram-negative urinary pathogens; however, the extrapolation of current CLSI and EUCAST MIC breakpoints to pathogens not specified by standard methods requires further study and is currently not recommended.